Results 141 to 150 of about 28,958 (244)

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

Journal of Thrombosis and Haemostasis, 2017
I. Gouin-Thibault, I. Gouin-Thibault, X. Delavenne, A. Blanchard, A. Blanchard, V. Siguret, V. Siguret, J. Salem, J. Salem, C. Narjoz, P. Gaussem, P. Gaussem, P. Beaune, P. Beaune, C. Funck-Brentano, C. Funck-Brentano, Michel Azizi, P. Mismetti, M. Loriot, M. Loriot   +19 more
semanticscholar   +1 more source

Current Status of the Safety and Efficacy of Antidotes for Direct Oral Anticoagulants in Japan. [PDF]

JACC Asia
Kodani E.
europepmc   +1 more source

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Circulation, 2014
S. Schulman, A. Kakkar, S. Goldhaber, S. Schellong, H. Eriksson, P. Mismetti, A. Christiansen, J. Friedman, F. Le Maulf, N. Peter, C. Kearon   +10 more
semanticscholar   +1 more source

Dabigatran Prevents Lipopolysaccharide-Mediated Apoptosis in Zebrafish Through a Thrombin-Independent Mechanism. [PDF]

Shock
Fleischmann AIT, Woodhams WH, Mouayed R, Joseph T, Sui X, Yaman M, Oehlers S, Shavit JA, Jacob VA.   +8 more
europepmc   +1 more source

Dabigatran (October 2011)

Cleveland Clinic Journal of Medicine, 2011
openaire   +2 more sources

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

Journal of the American College of Cardiology, 2014
P. Reilly, T. Lehr, S. Haertter, S. Connolly, S. Yusuf, J. Eikelboom, M. Ezekowitz, G. Nehmiz, Susan Wang, L. Wallentin   +9 more
semanticscholar   +1 more source

Research Advances in Timing of Anticoagulant Therapy Following Cardioembolic Stroke. [PDF]

Clin Med Insights Cardiol
Rousidanmu M, Yang N, Yang P, Yan N.
europepmc   +1 more source

DABIGATRAN ACYLGLUCURONIDE, THE MAJOR HUMAN METABOLITE OF DABIGATRAN:

Abstracts of Annual meeting of Japanese Society for the Study of Xenobiotics, 2010
Ebner, Thomas, Wagner, Klaus, Wienen, Wolfgang   +2 more
openaire   +1 more source

Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation.

JAMA Netw Open
Bradley MC, Simon AL, Kolonoski J, Graham DJ, Zhang R, Connolly JG.   +5 more
europepmc   +1 more source

Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Chai H, Huo J, Chen H.
europepmc   +1 more source